Takuro Noguchi

6.7k total citations · 1 hit paper
49 papers, 3.3k citations indexed

About

Takuro Noguchi is a scholar working on Oncology, Surgery and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Takuro Noguchi has authored 49 papers receiving a total of 3.3k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Oncology, 15 papers in Surgery and 14 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Takuro Noguchi's work include Cancer Immunotherapy and Biomarkers (9 papers), Immunotherapy and Immune Responses (8 papers) and Immune Cell Function and Interaction (6 papers). Takuro Noguchi is often cited by papers focused on Cancer Immunotherapy and Biomarkers (9 papers), Immunotherapy and Immune Responses (8 papers) and Immune Cell Function and Interaction (6 papers). Takuro Noguchi collaborates with scholars based in Japan, United States and Switzerland. Takuro Noguchi's co-authors include Robert D. Schreiber, Matthew M. Gubin, Michael D. Buck, Erika L. Pearce, Gerritje J. W. van der Windt, Qiongyu Chen, David O’Sullivan, Jing Qiu, Elena Tonc and Chih‐Hao Chang and has published in prestigious journals such as Cell, The Journal of Immunology and Cancer Research.

In The Last Decade

Takuro Noguchi

45 papers receiving 3.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Metabolic Competition in the Tumor Microenvironment Is a Driver of Cancer Progression

2015 2.3k citations Chih‐Hao Chang, Jing Qiu et al. Cell profile →

Peers

Countries citing papers authored by Takuro Noguchi

Since Specialization

Citations

This map shows the geographic impact of Takuro Noguchi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Takuro Noguchi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Takuro Noguchi more than expected).

Fields of papers citing papers by Takuro Noguchi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Takuro Noguchi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Takuro Noguchi. The network helps show where Takuro Noguchi may publish in the future.

Co-authorship network of co-authors of Takuro Noguchi

This figure shows the co-authorship network connecting the top 25 collaborators of Takuro Noguchi. A scholar is included among the top collaborators of Takuro Noguchi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Takuro Noguchi. Takuro Noguchi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Multicenter phase II trial of trastuzumab and docetaxel for HER2-positive salivary gland cancer 2025 ·Japanese Journal of Clinical Oncology ·Satoshi Kano, (unknown), Ichiro Kinoshita, Yuichiro Tada, Kei Ijichi, Tomoko Yamazaki, Yasushi Shimizu, Yutaka Hatanaka, Hitoshi Tsuda, Shojiroh Morinaga, Yoshihiro Matsuno, Yoichi M. Ito, Naoki Nishimoto, Keiko Kobayashi, Toshiyuki Isoe, Takuro Noguchi, Akihiro Homma, Hirotoshi Dosaka‐Akita	1
2	Expression of Karyopherin Alpha 2 and Karyopherin Beta 1 Correlate with Poor Prognosis in Gastric Cancer 2022 ·Oncology ·(unknown), Ichiro Kinoshita, Akira Suzuki, (unknown), Jun Taguchi, Takuro Noguchi, Satoshi Takeuchi, Yasushi Shimizu, (unknown), Junichi Suzuki, Hirotoshi Dosaka‐Akita	4
3	Suitability of Oral Rehydration Solution (ORS) for Use in the Cisplatin Short Hydration Method 2022 ·Anticancer Research ·Yoshitaka Saito, Yoh Takekuma, Masaki Kobayashi, Naofumi Shinagawa, Takuro Noguchi, Satoshi Takeuchi, Yasushi Shimizu, Ichiro Kinoshita, Hirotoshi Dosaka‐Akita, Mitsuru Sugawara	6
4	Risk Factor Analysis for the Occurrence of Severe Adverse Effects in Eribulin Treatment 2022 ·Anticancer Research ·Yoshitaka Saito, Yoh Takekuma, Takashi Takeshita, Takuro Noguchi, Satoshi Takeuchi, Yasushi Shimizu, Ichiro Kinoshita, Hirotoshi Dosaka‐Akita, Mitsuru Sugawara	4
5	Clinical Analysis of Extrapulmonary Neuroendocrine Carcinoma: A Retrospective and Single Institution Experience 2022 ·Chemotherapy ·(unknown), Takuro Noguchi, Nodoka Sekiguchi, Takashi Kobayashi, Shintaro Kanda, (unknown), Tomonori Minagawa, (unknown), Takeji Umemura, Tomonobu Koizumi	1
6	Serial Cancer Development Three Times in a Patient with Fanconi Anemia 2021 ·Case Reports in Oncology ·(unknown), (unknown), (unknown), Hiroshi Kuraishi, (unknown), Ichiro Ito, Takuro Noguchi, Nodoka Sekiguchi, Shintaro Kanda, Tomonobu Koizumi	1
7	A Rare Distant Metastasis of Papillary Cystadenocarcinoma Arising from Maxillary Gingiva 2020 ·Case Reports in Oncology ·(unknown), (unknown), Keita Tsukada, Takuro Noguchi, Toshirou Fukushima, Takashi Kobayashi, Nodoka Sekiguchi, (unknown), Tomonobu Koizumi	0
8	[Desensitization Therapy for Osimertinib in Patients Who Developed Toxic Erythema - Two Case Reports]. 2019 ·PubMed ·Hiroaki Watanabe, (unknown), (unknown), Takuro Noguchi, (unknown), (unknown), Nodoka Sekiguchi, Shigeru Ohmori, Tomonobu Koizumi	1
9	A Case of Unresectable Pulmonary Artery Intimal Sarcoma with Prolonged Survival by Chemotherapy 2019 ·Case Reports in Oncology ·Takuro Noguchi, (unknown), Toshirou Fukushima, (unknown), Takashi Kobayashi, Nodoka Sekiguchi, Keiko Mamiya, Tomonobu Koizumi	4
10	Targeted therapy with trastuzumab for epidermal growth factor receptor 2 (HER2)‑positive advanced salivary duct carcinoma: A case report 2019 ·Molecular and Clinical Oncology ·(unknown), Nodoka Sekiguchi, (unknown), Takuro Noguchi, Toshirou Fukushima, Takashi Kobayashi, (unknown), Shin‐ichi Yamada, Tomonobu Koizumi	11
11	High-Dimensional Analysis Delineates Myeloid and Lymphoid Compartment Remodeling during Successful Immune-Checkpoint Cancer Therapy 2018 ·Cell ·Matthew M. Gubin, Ekaterina Esaulova, Jeffrey P. Ward, Olga Malkova, Daniele Runci, Pamela Wong, Takuro Noguchi, Cora D. Arthur, Wei Meng, Elise Alspach, Ruan F.V. Medrano, Catrina C. Fronick, Michael Fehlings, Evan W. Newell, Robert S. Fulton, Kathleen C. F. Sheehan, Stephen T. Oh, Robert D. Schreiber, Maxim N. Artyomov	275
12	Temporally Distinct PD-L1 Expression by Tumor and Host Cells Contributes to Immune Escape 2017 ·Cancer Immunology Research ·Takuro Noguchi, Jeffrey P. Ward, Matthew M. Gubin, Cora D. Arthur, Sang Hun Lee, Jasreet Hundal, M. J. Selby, Robert F. Graziano, Elaine R. Mardis, Alan J. Korman, Robert D. Schreiber	242
13	Metabolic Competition in the Tumor Microenvironment Is a Driver of Cancer Progression breakdown → 2015 ·Cell ·Chih‐Hao Chang, Jing Qiu, David O’Sullivan, Michael D. Buck, Takuro Noguchi, Jonathan D. Curtis, Qiongyu Chen, (unknown), Matthew M. Gubin, Gerritje J. W. van der Windt, Elena Tonc, Robert D. Schreiber, Edward J. Pearce, Erika L. Pearce	2297
14	Establishment of animal models to analyze the kinetics and distribution of human tumor antigen-specific CD8+ T cells 2013 ·Vaccine ·Daisuke Muraoka, Hiroyoshi Nishikawa, Takuro Noguchi, Linan Wang, Naozumi Harada, Eiichi Sato, Immanuel F. Luescher, Eiichi Nakayama, Takuma Kato, Hiroshi Shiku	6
15	Intracellular Tumor-Associated Antigens Represent Effective Targets for Passive Immunotherapy 2012 ·Cancer Research ·Takuro Noguchi, Takuma Kato, Linan Wang, Yuka Maeda, Hiroaki Ikeda, Eiichi Sato, Alexander Knuth, Sacha Gnjatic, Gerd Ritter, Shimon Sakaguchi, Lloyd J. Old, Hiroshi Shiku, Hiroyoshi Nishikawa	43
16	Extrapleural hematoma as a complication following thoracotomy for pulmonary lobectomy 2011 ·General Thoracic and Cardiovascular Surgery ·Takuro Noguchi, Yasuhiro Hida, Kichizo Kaga, (unknown), Hiroto Niizeki, Satoshi Kondo	3
17	Two Distinct Mechanisms of Augmented Antitumor Activity by Modulation of Immunostimulatory/Inhibitory Signals 2010 ·Clinical Cancer Research ·(unknown), Hiroyoshi Nishikawa, Daisuke Muraoka, Linan Wang, Takuro Noguchi, Eiichi Sato, Satoshi Kondo, James P. Allison, Shimon Sakaguchi, Lloyd J. Old, Takuma Kato, Hiroshi Shiku	106
18	Relationship between Sugi Butt-Rot Disease and Norlignans in the Heartwood 2009 ·Mokuzai Gakkaishi ·(unknown), Takuro Noguchi, Hideaki Ichiura	3
19	Comparison of therapeutic efficacy of neuroses between CM6912 (ethyl loflazepate) and diazepam in a double-blind trial 1989 ·Progress in Neuro-Psychopharmacology and Biological Psychiatry ·Mitsukuni Murasaki, Atsuyoshi Mori, Takuro Noguchi, (unknown), Kazuo Hasegawa, (unknown), Kunitoshi Kamijima	3
20	Pharmacokinetics and neuroendocrinological studies of bromperidol in schizophrenic patients. 1986 ·Rinsho yakuri/Japanese Journal of Clinical Pharmacology and Therapeutics ·Yoshio Igarashi, (unknown), Takuro Noguchi, (unknown), (unknown), (unknown)	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact